|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7950 USD | +1.22% |
|
+2.90% | -84.45% |
| 05/08 | VolitionRx Limited Publishes First Peer-Reviewed Paper On Capture-Seq Liquid Biopsy Technology | CI |
| 30/07 | Volitionrx Limited Provides Update on Nu.Q Nets Product Platform and Clinical Evidence | CI |
| Market Cap | 66.23L 57.36L 53.47L 49.18L 92.84L 63Cr 93.87L 6.28Cr 2.47Cr 32Cr 2.49Cr 2.43Cr 104.35Cr | P/E 2026 * |
-0.36x | P/E 2027 * | -0.57x |
|---|---|---|---|---|---|
| Enterprise Value | 66.23L 57.36L 53.47L 49.18L 92.84L 63Cr 93.87L 6.28Cr 2.47Cr 32Cr 2.49Cr 2.43Cr 104.35Cr | EV / Sales 2026 * |
2.67x | EV / Sales 2027 * | 1.16x |
| Free-Float |
91.38% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: VolitionRx Limited
| 1 day | +1.22% | ||
| 1 week | +2.90% | ||
| Current month | +10.71% | ||
| 1 month | -43.21% | ||
| 3 months | -65.88% | ||
| 6 months | -83.91% | ||
| Current year | -84.45% |
| 1 week | 0.69 |  | 0.91 |
| 1 month | 0.69 | | 1.53 |
| Current year | 0.69 | | 7.73 |
| 1 year | 0.69 | | 15.1 |
| 3 years | 0.69 | | 27.6 |
| 5 years | 0.69 | | 82.8 |
| 10 years | 0.69 | | 136.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 55 | 06/10/2011 |
Terig Hughes
DFI | Director of Finance/CFO | 56 | 01/02/2021 |
Andrew Retter
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Cameron Reynolds
BRD | Director/Board Member | 55 | 06/10/2011 |
Alan Colman
BRD | Director/Board Member | 77 | 06/10/2011 |
Phillip Barnes
BRD | Director/Board Member | 64 | 09/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/03/26 | Tax | Chief Technology Officer | 5,310 | 0.0039% | ||
| 17/03/26 | Tax | Company Secretary | 3,948 | 0.0029% | ||
| 01/03/26 | Concord International, Inc.
| Other | Company | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.22% | +2.90% | -93.79% | -96.94% | 66.23L | |
| +0.20% | +9.04% | +122.62% | +260.18% | 392.61Cr | |
| -0.56% | -17.16% | +84.53% | +80.63% | 371Cr | |
| -3.38% | +28.49% | +254.09% | +309.91% | 235.39Cr | |
| +1.15% | +5.65% | -26.06% | -34.64% | 224.24Cr | |
| -0.46% | -4.82% | +57.82% | -40.06% | 193.78Cr | |
| -0.31% | -2.73% | +173.93% | -44.26% | 95Cr | |
| +0.36% | +10.22% | -4.59% | +10.87% | 90Cr | |
| -0.73% | +1.89% | -39.05% | -11.75% | 51Cr | |
| +0.24% | +22.59% | +1.82% | - | 51Cr | |
| Average | -0.23% | +5.65% | +53.13% | +48.21% | 170.42Cr | |
| Weighted average by Cap. | -0.46% | +3.77% | +93.14% | +112.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 24.78L 21.46L 20L 18.4L 34.73L 24Cr 35.12L 2.35Cr 92.26L 12Cr 93.06L 91L 39Cr | 57.33L 49.66L 46.29L 42.57L 80.37L 55Cr 81.27L 5.44Cr 2.13Cr 27Cr 2.15Cr 2.11Cr 90Cr |
| Net income | -2.22Cr -1.92Cr -1.79Cr -1.65Cr -3.11Cr -211.12Cr -3.15Cr -21Cr -8.27Cr -105.63Cr -8.34Cr -8.16Cr -349.85Cr | -1.96Cr -1.7Cr -1.58Cr -1.46Cr -2.75Cr -186.55Cr -2.78Cr -19Cr -7.31Cr -93Cr -7.37Cr -7.21Cr -309.14Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | $0.7950 | +1.22% | 99,38,048 |
| 04/26/04 | $0.7854 | -1.81% | 2,66,358 |
| 03/26/03 | $0.7999 | +11.39% | 2,03,212 |
| 31/26/31 | $0.7181 | -10.20% | 2,52,637 |
| 30/26/30 | $0.7997 | +3.51% | 10,06,754 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VNRX Stock
Select your edition
All financial news and data tailored to specific country editions
